VANI
Vivani Medical·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 0
Consensus Rating "Strong Buy"
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About VANI
Vivani Medical, Inc.
A clinical stage company, develops various implants that treat chronic diseases with high unmet medical need
1350 S. Loop Road, Alameda, CA 94502
--
Vivani Medical, Inc., was incorporated under the laws of the State of California on December 17, 2009. Vivani Medical, Inc., a preclinical stage biopharmaceutical company, utilizes its proprietary nano-portal technology to develop miniaturized subcutaneous implants for long-term, near-constant rate delivery of multiple drugs for the treatment of chronic diseases.
Company Financials
EPS
VANI has released its 2025 Q2 earnings. EPS was reported at -0.12, versus the expected -0.1, missing expectations. The chart below visualizes how VANI has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
